Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- PMID: 19291785
- DOI: 10.1002/hep.22848
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Abstract
The role played by the gut in nonalcoholic fatty liver disease (NAFLD) is still a matter of debate, although animal and human studies suggest that gut-derived endotoxin may be important. We investigated intestinal permeability in patients with NAFLD and evaluated the correlations between this phenomenon and the stage of the disease, the integrity of tight junctions within the small intestine, and prevalence of small intestinal bacterial overgrowth (SIBO). We examined 35 consecutive patients with biopsy-proven NAFLD, 27 with untreated celiac disease (as a model of intestinal hyperpermeability) and 24 healthy volunteers. We assessed the presence of SIBO by glucose breath testing (GBT), intestinal permeability by means of urinary excretion of (51)Cr-ethylene diamine tetraacetate ((51)Cr-EDTA) test, and the integrity of tight junctions within the gut by immunohistochemical analysis of zona occludens-1 (ZO-1) expression in duodenal biopsy specimens. Patients with NAFLD had significantly increased gut permeability (compared with healthy subjects; P < 0.001) and a higher prevalence of SIBO, although both were lower than in the untreated celiac patients. In patients with NAFLD, both gut permeability and the prevalence of SIBO correlated with the severity of steatosis but not with presence of NASH.
Conclusions: Our results provide the first evidence that NAFLD in humans is associated with increased gut permeability and that this abnormality is related to the increased prevalence of SIBO in these patients. The increased permeability appears to be caused by disruption of intercellular tight junctions in the intestine, and it may play an important role in the pathogenesis of hepatic fat deposition.
Comment in
-
The gut-liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance?Hepatology. 2009 Jun;49(6):1790-2. doi: 10.1002/hep.23036. Hepatology. 2009. PMID: 19475679 No abstract available.
Similar articles
-
Liver damage in human small intestinal bacterial overgrowth.Am J Gastroenterol. 1998 Feb;93(2):234-7. doi: 10.1111/j.1572-0241.1998.00234.x. Am J Gastroenterol. 1998. PMID: 9468250
-
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261. Nutrients. 2022. PMID: 36558421 Free PMC article. Review.
-
Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability.Eur J Clin Invest. 2012 Apr;42(4):439-46. doi: 10.1111/j.1365-2362.2011.02609.x. Epub 2011 Oct 24. Eur J Clin Invest. 2012. PMID: 22023490
-
PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS.Arq Gastroenterol. 2020 Oct-Dec;57(4):471-476. doi: 10.1590/S0004-2803.202000000-82. Arq Gastroenterol. 2020. PMID: 33331479
-
The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease.Nutrients. 2014 Dec 3;6(12):5583-99. doi: 10.3390/nu6125583. Nutrients. 2014. PMID: 25479248 Free PMC article. Review.
Cited by
-
Probiotic as a novel treatment strategy against liver disease.Hepat Mon. 2013 Feb 25;13(2):e7521. doi: 10.5812/hepatmon.7521. Print 2013 Feb. Hepat Mon. 2013. PMID: 23610585 Free PMC article.
-
Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease.Int J Clin Exp Pathol. 2015 Apr 1;8(4):3648-58. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26097546 Free PMC article.
-
The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases.Int J Biol Sci. 2020 Jun 23;16(13):2357-2366. doi: 10.7150/ijbs.46405. eCollection 2020. Int J Biol Sci. 2020. PMID: 32760203 Free PMC article. Review.
-
Diabetes mellitus-Progress and opportunities in the evolving epidemic.Cell. 2024 Jul 25;187(15):3789-3820. doi: 10.1016/j.cell.2024.06.029. Cell. 2024. PMID: 39059357 Review.
-
The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver Disease.Integr Med Insights. 2016 Apr 27;11:19-25. doi: 10.4137/IMI.S31451. eCollection 2016. Integr Med Insights. 2016. PMID: 27147819 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources